Your search matched 249 results
The Week That Was: No Rest for the Wicked | Blog
We’ve recapped Scott Gottlieb’s eventful penultimate week at the FDA in this week’s edition of The Week That Was.
The Week That Was: Green, Red, White and Blue | Blog
This week's edition of The Week That Was details how health and medical groups are taking action to address the “greatest public health challenge of the 21st century” and what you need to know from a busy week in healthcare policy.
The Week That Was: That LaLa feeling | Blog
This week’s edition of The Week That Was looks at how not to spin a poor earnings report.
The Week That Was: Nowhere Left To Go | Blog
We’ve analyzed their progress in this week’s issue of The Week That Was.
The Week That Was: Farewell, Yellow Brick Road | Blog
In this week’s edition of The Week That Was, we explain one way they can communicate value.
A busy week in Washington | Blog
So, a lot happened in Washington this week… which we won’t be commenting on!
Question of the Week: Who’s Responsible for Addiction? | Blog
Read this and more in this week's TWTW!
The Week That Was: A Less Sharp FDA? | Blog
This week’s edition of The Week That Was takes a look and provides insights from a new ICER report.
The Week That Was: Dude, where’s my paycheck? | Blog
Take a look at the latest insights in this week’s issue of The Week That Was.
The Week That Was: Re-Wear Your Happy Hat | Blog
We’ve got a recap for you in this week’s edition of The Week That Was.
The Week That Was: Crises in Communications | Blog
No matter whether you were the lone staffer in your office or relaxing on a beach somewhere this past week, we’ve got the run down on the latest healthcare headlines—the good, the bad and the ugly—to help you get you back up to speed.
Read on for more in The Week That Was. | Blog
It was another intense week in healthcare headlines.
The Week That Was: Alexa, what do you know about drug pricing? | Blog
House of Representatives for a vote in just a few weeks.
The Week That Was: Thank u, next | Blog
The anti-vaccination movement is causing challenges not just in healthcare, but now in tech.
The Week That Was: We only ride in style | Blog
Employers wield enormous influence in deciding the care their employees receive – yet they aren’t always considered a core “stakeholder” in the healthcare debate.
The Week That Was: Smile like You Mean It | Blog
As the industry awaits a potential executive order on transparency around healthcare costs, we took a look at some transparency tools, and where they’re falling short.
The Week That Was: Put Your Font to Work | Blog
You may have seen a lot of recent reporting on “loss of coverage” for Americans.
The Week That Was: Bye-bye midtown uniform | Blog
Prescription delivery services – like Hims, Roman and Kick – are popping up all over the place, prompting concerns about regulation.
The Week That Was: You’ve GOAT to be kidding me | Blog
Everyone seems to be talking about digital health, but what does that really look like in action?
The Week That Was: Ready, Set, Bird Box Challenge | Blog
In case you haven’t heard, it’s the New Year.
The Week That Was: "I don't know" x 600 | Blog
Climate change is named a top 10 health threat and we’ve broken down the conundrum for pharma companies regarding activating on the issue.
The Week That Was: No one likes a bad kiss | Blog
Drug makers aren’t the only ones under pressure for high costs.
The Week That Was: Come on, show 'em what you're worth | Blog
Policymakers continue their focus on drug pricing and may also have eyes for changes to the Orphan Drug Act.
The Week That Was: Opioid Pledges Get Renewed Coverage | Blog
Our team kept an eye on a number of stories about opioid “pledges,” top-line data communications and, as always, drug pricing.
The Week That Was: Can You Hear Me Now? | Blog
As digital health continues to grow in prevalence, so do patient information databases.
This Week’s Healthcare “Breakdown” (channeling Tom Petty) | Blog
President Trump and HHS Secretary Azar gave a slightly delayed, much anticipated speech on the Administration’s Blueprint to lower drug prices.
Already have a RSS feed reader?
